Software as a Medical Device (SaMD): FDA, EU MDR, and AI Act Compliance Guide

Software as a Medical Device represents one of the most consequential and rapidly evolving categories in global healthcare regulation. From AI-powered diagnostic algorithms to clinical decision support platforms and patient-facing mobile applications, SaMD is transforming how medicine is practiced, monitored, and delivered. Yet this transformation arrives with a regulatory complexity that can make or break a product's path to market.

In 2025, three regulatory frameworks converge to govern SaMD in the world's largest healthcare markets: the FDA's expanded SaMD guidance under the De Novo and 510(k) pathways, the EU Medical Device Regulation (EU MDR 2017/745) and its in vitro diagnostic counterpart (EU IVDR 2017/746), and the landmark EU Artificial Intelligence Act, which took phased effect beginning August 2024. For any organization developing software that touches clinical decisions, patient outcomes, or diagnostic functions, compliance with all three is no longer optional. It is the price of market access.

This white paper provides a comprehensive, practitioner-focused compliance guide covering the classification systems, documentation requirements, quality system obligations, and submission pathways for SaMD under each framework. It addresses the particular complexity facing AI/ML-based SaMD, where algorithms that learn and change over time challenge the foundational assumptions of traditional regulatory review. It also explains how Cloudtheapp's validated, AI-powered quality management platform provides the compliance infrastructure that SaMD developers need to navigate this environment with confidence.